STOCK TITAN

Morgan Stanley lists 1,037,487 ADPT shares (NASDAQ: ADPT)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

ADPT Form 144 notice lists proposed sales of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services. The filing shows a proposed sale dated 03/03/2026 tied to an exercise of stock options for 1,037,487 shares and earlier restricted stock units dated 03/04/2022 for 169,174 shares. The securities are listed on NASDAQ.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Adaptive Biotechnologies

NASDAQ:ADPT

ADPT Rankings

ADPT Latest News

ADPT Latest SEC Filings

ADPT Stock Data

2.47B
150.48M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
SEATTLE